Infrequent transition to direct oral anticoagulants in patients with cancer

CONCLUSIONS. In patients with cancer, the one-year cumulative incidence of switching from LMWH to DOAC was less-t 35% in patients eligible for DOAC, revealing a potential for improved anticoagulant treatment. Furthermore, contemporary data elaborated on potential DDIs between DOACs/antineoplastic agents.FUNDING: "Helsefonden" (21-B-0350) and the "Karen Elise Jensens Fonden" (29-4-2021) funded the study.TRIAL REGISTRATION: Not relevant.PMID:38314737 | DOI:10.61409/A05230278

Source: Danish Medical Journal - February 5, 2024 Category: General Medicine Authors: Nina Nouhravesh Caroline Sindet-Pedersen Maja Hellfritzsch Ali Akil Al-Alak Thomas K ümler Erik L Grove Morten Lamberts Source Type: research